The FDA will have 60 days "to determine whether the MDMA-AT NDA application will be accepted for review and whether it will be a priority or standard review. The estimate timeline is six months or ten months.
https://psychedelicspotlight.com/wp-content/uploads/2023/12/new-images-PS-1200-×-802-px-2023-12-13T105218.526.png8021200Maria Holyanovahttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngMaria Holyanova2023-12-13 16:47:202024-01-18 20:26:15MDMA-Assisted Therapy for PTSD Edges Toward Acceptance – When Might It Be Approved?
The blue coloration of magic mushrooms is a chemical reaction triggered by damage or stress. This process, similar to how an apple turns brown when cut, is due to the oxidation of psilocybin, the psychoactive compound in these mushrooms.
One possible reason for this phenomenon is psilocybin’s interaction with the thalamus, the section of our brain that receives sensory information and relays it to different brain areas for processing.
https://psychedelicspotlight.com/wp-content/uploads/2023/12/fO2jujB2tqupSt0knhCI-1-ws45k.jpg8321216Phil Dubleyhttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngPhil Dubley2023-12-07 18:59:032023-12-07 23:15:22Why Do We Feel Like We Can Score 40/20 in Visual Acuity on Low Doses of Psychedelics?
The evidence pile for psilocybin’s efficacy in treating depression is growing with new data demonstrating 79% remission rates after two doses. Meanwhile, early trials hint at MEAI’s efficacy in treating obesity, ketamine studies suggest a single dose is effective in treating anxiety and discussions arise about psychedelic use and its capacity to birth new environmentalists.
https://psychedelicspotlight.com/wp-content/uploads/2023/12/new-images-PS-1200-×-802-px-2023-12-01T113116.878.png8021200Maria Holyanovahttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngMaria Holyanova2023-12-01 17:09:432023-12-01 17:42:20The Biggest Psychedelic News This Week: November 27th – December 1st
Classic psychedelics might effectively kill pain with even greater vigor over time, sharply contrasting with opioids.
https://psychedelicspotlight.com/wp-content/uploads/2023/11/new-images-PS-1200-×-802-px-83.png8021200Elena Schmidthttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngElena Schmidt2023-11-29 19:59:332023-12-01 16:55:16New Study Says LSD and Psilocybin Could Outperform Opioids for Pain, Without Developing Tolerance
Tidal Wave mushrooms have made a splash in the psychedelic community since their creation, and for good reason. This hybrid strain, created by Magic Myco and winner of the inaugural Psilocybin Cup, wowed users due to its unprecedented potency.
https://psychedelicspotlight.com/wp-content/uploads/2023/11/new-images-PS-1200-×-802-px-2023-11-24T135518.927.png8021200Phil Dubleyhttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngPhil Dubley2023-11-28 03:06:392023-11-28 15:25:36Tidal Wave Mushrooms: A Guide to One of the Most Potent Varieties Ever Tested
Psilocybin use shows reduced psychological distress in individuals with adverse childhood experiences, while microdosing shows a "both and" approach to treating ADHD.
https://psychedelicspotlight.com/wp-content/uploads/2023/11/new-images-PS-1200-×-802-px-2023-11-24T123450.779.png8021200Maria Holyanovahttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngMaria Holyanova2023-11-24 18:12:222023-11-24 18:12:25The Biggest Psychedelic News This Week: November 20th-24th
A new study exploring real-world psychedelic microdosing for ADHD could help reimagine the way we perceive and treat the condition.
https://psychedelicspotlight.com/wp-content/uploads/2023/11/new-images-PS-1200-×-802-px-80.png8021200Elena Schmidthttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngElena Schmidt2023-11-22 20:23:292023-11-25 17:11:04Stacking Psychedelic Microdoses with ADHD Medication? New Study Hints “Both And” Could Work
Get a roundup of Psychedelic news stories in your inbox
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
MDMA-Assisted Therapy for PTSD Edges Toward Acceptance – When Might It Be Approved?
Business, ResearchWhy Do Magic Mushrooms Bruise Blue? Mystery Solved
BeginnersWhy Do We Feel Like We Can Score 40/20 in Visual Acuity on Low Doses of Psychedelics?
Beginners, ResearchPsychedelic Holiday Gift Guide 2023: 11 Ideas for Your Favorite Soul Seekers
Culture5 Legal Ways to Explore Psychedelic Experiences
Beginners, CultureThe Biggest Psychedelic News This Week: November 27th – December 1st
Policy, ResearchNew Study Says LSD and Psilocybin Could Outperform Opioids for Pain, Without Developing Tolerance
ResearchTidal Wave Mushrooms: A Guide to One of the Most Potent Varieties Ever Tested
Beginners, EducationThe Biggest Psychedelic News This Week: November 20th-24th
Policy, ResearchStacking Psychedelic Microdoses with ADHD Medication? New Study Hints “Both And” Could Work
Research